Bayesian Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Sell |
|
|||||
|
2025
Q1 | $861K | Sell |
|
|||||
|
2024
Q4 | $2.14M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $376K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.62M | Buy |
|
|||||
|
2022
Q3 | $693K | Buy |
|
|||||
|
2022
Q2 | $307K | Buy |
|
|||||
|
2022
Q1 | $244K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $329K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $2.01M | Buy |
|
|||||
|
2017
Q2 | $1.53M | Buy |
|